Introduction
Bovine herpesvirus I (BHV-1), also known as infectious bovine rhinotracheitis virus, is associated with a wide variety of clinical symptoms in respiratory, genital and nervous system infections of cattle (Kahrs, 1977) . BHV-1 envelope contains a number of glycoproteins at least three of which, gB (gI), gC (glII) and gD (gIV), appear to be involved in virus neutralization (Van Drunen LitteI-Van Den Hurl< & Babiuk, 1986; Dubuisson et at., 1992) . Epitopes on each of these glycoproteins are targets for neutralizing monoclonal antibodies (MAbs) (Marshall et al., 1988) . Neutralizing antibodies can inhibit virus binding to the specific cell surface receptors by binding to the viral attachment protein (VAP) (Dimmock, 1987) . They can also inhibit virus penetration depending on the mechanism of virus entry (Gollins & Porterfield, 1986) . For herpes simplex virus type I (HSV-1), studies involving antibody inhibition for virus attachment (Fuller & Spear, 1985) indicate use of envelope Author for correspondence: Harish C. Minocha. Fax + 1 913 532 5884. e-mail minocha@vet.ksu.edu glycoproteins gB, gC and gD as the major VAPs. Recent reports also offer strong evidence for a cascade of multiple virus~:elI interactions in HSV infection (Fuller & Lee, 1992; McCIain & Fuller, 1994) . The initial attachment involves gB and gC (Herold et al., i991; Kuhn et al., 1990) followed by stable attachment by gD (Lee & Fuller, 1993) . A recent study emphasizes the role of gB in gC-negative HSV-1 attachment to cells (Herold et al., 1994) . Like HSV-1, BHV-1 belongs to the subfamily Alphaherpesvirinae and encodes homologues of the glycoproteins gB, gC and gD. Virus attachment studies involving gC deletion mutants, MAb-mediated neutralization and purified gIycoproteins indicated that besides gC, gB and gD also participate in BHV-1 attachment (Liang et aI., 1991) . The study also suggested that gB, gC and gD may recognize different binding sites (receptors) on the surfaces of permissive cells. For BHV-1 at least two different cellular receptors have been identified, one of which was a heparin-like moiety that was found to interact specifically with gC (Okazaki et al., 1991) and the other that reacted with gD (Thaker et al., 1994) . Whether these receptors act as co-receptors or in a sequential manner has not been determined.
Virus receptors are structures on a cell surface the binding of which to the virus is followed by a biologically relevant response, usually infection of the cell. Identification of virus receptors has proven to be extremely difficult because of the following reasons: (i) virus particles, besides binding to cells via specific ceil receptors in a biologically relevant manner, also adhere to cells in a non-specific manner followed by internalization through fluid phase or constitutive endocytosis (Steinman et al., 1983) ; (ii) existence of low numbers of specific receptors (Johnson el aI., 1990) ; (iii) possibility of multiple receptors for a single virus, as in case of human immunodeficiency virus 1 (HIV-1) (Fantini el aI., 1993) and HSV (WuDunn & Spear, 1989; Johnson et aI., 1990) ; and (iv) involvement of intermediate molecules (Homsy et aL, 1989; Pontisso et al., 1989) .
It has been well established that anti-idiotypic antibodies (anti-ids) may contain structures that are similar to the epitopes of foreign antigens and mimic their antigenic determinants (Jerne, 1974) . Use of such 'internal image' anti-ids as vaccines for infectious diseases because of their ability to substitute for epitopes displayed on the infectious organisms has been reported in many virus systems (Lathey eta[., 1986; Schnick el al., 1987; Xuan et aI., 1991) . Besides using anti-ids as immunogens for a protective response against a particular infectious agent, their use as probes to detect the cell surface receptors for a given infectious agent has also been reported widely (Co et al., 1985; Ockenhouse et al., 1991; Xue & Minocha, 1993; Thaker et aI., 1994) . We produced and characterized a set of rabbit polyclonal anti-ids to BHV-1 glycoproteins gB, gC and gD (Orten el al., 1988; Abdelmagid et al., 1992) . One such internal image anti-id that blocked virus infection in cells was used as a probe to identify BHV-1 receptor in the present study. We hereby report a 56 kDa protein that was identified specifically by the internal image anti-id, anti-83. Hence, we suggest that this cell surface protein on MDBK cells may mediate BHV-1 attachment and, thus, may be a receptor candidate for BHV-1.
Methods • Cell and virus propagation. Madin-Darby bovine kidney
(MDBK) and bae lung (Tb.lLu) cells were grown in minimal essential medium (MEM) containing 10 % fetal bovine serum (FBS), supplemented with 10 % non-essential amino acids. MDBK and Tb.lLu are, respectively, permissive and non-permissive cell lines for BHV-1 infection. BHV-1 was grown on MDBK cells and purified as described earlier (Orten et aI., 1988) . Pseudorabies virus (PrV) was grown in a porcine kidney cell line (PK15). Virus titres were determined by plaque assay. BHV-1 virus stock had a titre of 6 × 101° p.f.u./m] with a protein concentration of 3 mg/m], whereas PrV stock had a titre of 3'7 x 109 p.f.u./ml with a protein concentration of 2'4 mg/ml. Biotin-labelled BHV-1 was obtained by using the methods described by Borrow & Oldstone (1992) . The concentration of the virus used in the binding assay using FACS analysis was established in initial optimization and saturation exper/ments. A typical binding assay was performed as described by Borrow & Oldstone (1992) . Briefly, a MDBK cell (I x 10 ~) suspension was incubated with biotinylated BHV-1 on ice for 45-60 min, followed by addition of avidin-FITC (Boehringer Mannheim). All steps were carried out on ice and cells were washed (three times) in cold PBS with 2 % FBS after each step. Dead cells were eliminated from analysis by finally staining cells with propidium iodide. In the inhibition assay, the biotinylated BHV-1 was preincubated with purified 56 kDa protein or 50 kDa protein (a control protein purified from the MDBK membrane preparation by similar methods) before the mixture was added to the cells.
• Antibodies and anti-ids. Polyclonal anti-iris were produced in New Zealand White rabbits and purified by affinity chromatography as described previously (Abdelmagid et a]., 1992) . In this study anti-83 (antiid) produced in rabbits against MAb 83 (specific for gB) was used as a probe. Anti-83 contains an internal image of BHV-1 gB as determined by initial characterization studies (Orten et al., 1988; Abdelmagid et al., 1992) and the experiments detailed in this report.
• Plaque reduction by anti-ids. MDBK cells grown to monolayers in 30 mm 2 Petri dishes were incubated with different concentrations of purified anti-83, anti-111B, anti-D89 [bovine viral diarrhoea virus (BVDV) anti-idJ, and anti-normal mouse immunoglobulin (NMG) for 30 rain at room temperature. Excess antibody was removed and i00 p.f.u, of BHV-1 was added to each Petri dish. After a further incubation for 30 rain at room temperature, excess virus was removed and cells were washed once with cold PBS and MEM-agar medium was added to the ceils. After 3 days of incubation at 37 °C, cells were stained with neutral red and plaques were counted. In another experiment, cell monolayers pre-treated with an optimum concentration of anti-83 or anti-D89, were infected with BHV-1, BVDV or PrV to determine the specificity of this anti-id. Cells pre-treated with PBS alone were used as the positive control against which the percentage of inhibition was calculated.
• Membrane preparations. Initial purification of membrane proteins was done using the method described by Borrow & Oldstone (1992) . Plasma membrane fraction from the total cellular membranes was isolated using a discontinuous sucrose gradient of 16 % to 60 % of sucrose in 10 mM-Tris-HC1 buffer at pH 7"6 (Esko e/~ al., 1977) . The membrane material at the 32-45 % sucrose interface was collected with a Pasteur pipette, diluted with 10 mM-Tris-HC1 buffer and pelleted at 30 000 r.p.m. The resulting pellet was dissolved in PBS and the protein concentration was determined using BCA protein assay (Pierce Immunology). The purified membrane proteins thus obtained were divided into 100 ~Lg aliquots and stored at -20 °C in the presence of protease inhibitors.
• Radioimmunoprecipitation assay (RIPA). Monolayer cultures
of MDBK cells alone or cells infected with BHV-1 were radiolabelled with {~SSJmethionine by methods described previously (Abdelmagid et al., 1992) . Briefly, confluent monolayers of MDBK cells initially starved in methionine-free MEM (2% FBS) for 6h, were provided with [aSSlmethionine (Du Pont)-containing unlabelled-methionine-free MEM for a minimum of 10 to 12 h. Cells were washed in PBS with 50 ,M-PMSF to remove unincorporated label and the membrane proteins were prepared by methods described above. RIPA was carried out using the purified plasma membrane proteins. Radiolabelled proteins were incubated with the anti-ids (anti-83, anti-D89 or preimmune rabbit sera) overnight at 4 °C followed by precipitation of the reaction complex using Protein A-Sepharose (Sigma). The Sepharose beads were washed, suspended in sample buffer and boiled for 5-10 min. The resulting preparation was analysed by SDS-PAGE (10 %) and autoradiography. In virus inhibition experiments the radiolabelled proteins were preincubated wi~h BHV-I, PrV or BVDV (at equal protein concentrations) for 1 h before adding anti-id. Alternatively, anti-ids (anti-83) were also preincubated with relevant (MAb 83) and irrelevant (MAb D89 or normal IP: 54.70.40.11
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:::::: mouse ]gG) antibodies for lh at 37 °C before adding them to radiolabelled membrane proteins to show the specificity of the anti-ids to their corresponding MAbs. To determine the protein nature of the receptor, the radiolabelled membranes were pre-treated with proteases (proteinase K or trypsin) for i h at 37 °C, Subsequently, the proteins were transferred onto ice briefly, followed by a 30 rain incubation at 4 °C to stop the enzyme activity, Protease-treated proteins were immunoprecipitated using anti-ids.
• Virus overlay protein blot assay (VOPBA). Radiolabelled BHV-1 was also prepared by methods described by Abdelmagid et al, (1992) . Labelled virions were harvested and purified by methods described earlier. The protein concentration (2'1 mg/ml) and the titres of purified BHV-1 (10 x 101°/ml) was determined before using it in a VOPBA. VOPBA was performed essentially by methods described by Borrow & Oldstone (1992) . In inhibition experiments membrane proteins were preincubated with purified anti-83 (50 ~tg) or control anti-D89 (50 ,g) before adding 100 I~g of radiolabelled BHV-1. Non-permissive bat lung cells (Tb.lLu) were analysed the same way as MDBK for the presence of cellular receptors for BHV-I using VOPBA. Results were analysed by autoradiography.
• Purification of 56 kDa protein from nitrocellulose membranes. The 56 kDa protein identified by anti-id was purified from nitrocellulose membranes by the methods described by Abou-Zeid et al. (1987) in order to determine its biological function as a cell surface receptor. Briefly, the pooled 56 kDa bands excised from the nitrocellulose membranes were dissolved in DMSO (250 gl/mm ~ of membrane) and recovered using carbonate-bicarbonate buffer (pH 9"6). The nitrocellulose particles bound to 56 kDa proteins were washed in RPMI I040
(2 x) before suspending them in PBS. The protein was eluted from nitrocellulose particles using either electro-elution or an elution buffer (50mM=Tris-HC1, Triton X-I00, 2% SDS; pH9-0) essentially as described by Szewczyk & Summers (I988) . The protein was concentrated by cold acetone precipitation (4 vols in dry ice/ethanol bath for 60 rain). The resulting pellet after centrifugation (15 000 r.p.m.) was suspended in PBS and the protein concentration was estimated using a BCA protein assay (Pierce). The purity of both the 56 kDa and control 50 kDa proteins was confirmed by the appearance of a single band in Coomassie bluestained SDS-PAGE gels.
Results
In this study anti-83 was used as a probe for identifying the cellular receptor for BHV-I. The credibility of this probe was established in our initial characterization experiments (Orten et al., 1988; Ahdelmagid et al,, 1992) . Most importantly, a plaque reduction assay was performed to determine whether the internal image anti-id can compete with BHV-1 for the cell surface receptor and thereby inhibit BHV-1 infection. Treatment of MDBK cells with anti-83 and anti-lllB reduced plaque formation by BHV-I (results not shown). For the receptor studies, anti-83, which gave maximum inhibition of virus infection (64 %) was chosen as a probe. Fig. 1 shows the specificity of this anti-83 by its ability to block BHV-1 infection. Monolayers pre-treated with either anti-83 or anti-D89 were infected with BHV-1, BVDV or PrV. Results illustrated that prior incubation of cells with anti-83 reduced the plaque formation only by BHV-1 (up to 65 %) but not that by BVDV. Control anti-id (anti-D89) inhibited BVDV (54%) but not BHV-I plaques (8%). In addition, treatment of cells with either anti-83 or anti-D89 had no significant effect on PrV infection.
Identification of 56 kDa cell membrane protein by anti-83
We next used anti-83 as a probe in immunoprecipitation to identify the cell surface protein involved in BHV-1 attachment. Anti-83 specifically identified a 56 kDa protein from the radiolabelled membrane protein preparation (Fig. 2) . Neither of the controls (anti-D89 or preimmune rabbit sera) reacted with the 56 kDa protein. Although there was background that appears to have resulted from non-specific binding of preimmune rabbit sera, there was no noticeable 56 kDa signal indicating that anti-83 was a specific probe.
Inhibition of immunoprecipitation of 56 kDa by MAbs
In order to determine the specificity of the antiqd an RIP inhibition experiment was conducted (Fig. 3 a) . Affinity-purified anti-ids when preincubated with equal concentrations of purified MAb 83 failed to immunoprecipitate 56 kDa, whereas the controls D89 (MAb against BVDV) and 34 (MAb against gC) did not interfere with the recognition of 56 kDa by anti-83.
Inhibition of immunoprecipitation of 56 kDa by BHV-1
The role of this 56 kDa protein as ceil surface receptor was evaluated by immunoprecipitation inhibition assay using BHV-1, PrV or BVDV (Fig. 3 b) . When radiolabelled membrane proteins were pre-treated with BHV-1, anti-83 failed to detect 56 kDa protein suggesting that BHV-1 bound to the same receptor protein that was recognized by the anti-id. Pretreatment of membrane proteins with BVDV did not obscure the signal indicating the specificity of this cell surface moiety for BHV-1 attachment. However, pretreatment of membrane proteins with PrV resulted in diminished 56 kDa signal indicating a certain degree of cross reactivity of this putative receptor with PrV.
Identification of the 56 kDa protein by VOPBA
We then proceeded to characterize by VOPBA the membrane protein(s) to which BHV-1 binds. In this method membrane proteins were separated by SDS-PAGE and transferred onto nitrocellulose membranes, which were successively incubated with radiolabelled virus. Fig. 4 illustrates the binding of BHV-1 to a 56 kDa protein from MDBK membrane preparations. When membrane proteins were preincubated with anti-83 the 56 kDa signal totally disappeared (lane 3). However, preincubation of membrane proteins with control anti-D89 antibody did not affect the recognition of 56 kDa protein.
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Non-permissive cells lack 56 kDa protein
Bat lung cells (Tb.ILu), which are non-permissive for BHV-1, were radiolabelIed and immunoprecipitated with anti-83 ( Fig. 5 ) or immunoblotted using radiolabelled BHV-1 itself as a probe in VOPBA (Fig. 4) . Lane 1 of Fig. 4 contains membrane proteins purified from non-permissive Tb.lLu. BHV-1 failed to identify 56 kDa protein suggesting that it was absent in Tb.lLu cells. Fig. 5 shows absence of 56 kDa band in Tb.lLu cell membranes when probed with anti-83. These results show that the non-permissive bat lung cells lacked the 56 kDa putative receptor protein for BHV-1.
Biochemical nature of the 56 kDa component
The nature of the 56 kDa protein was confirmed by pretreatment of radiolabelled membrane proteins or purified 56 kDa protein with proteases. RIPA and western blotting revealed no 56 kDa protein (Fig. 6 ) in protease-treated samples, suggesting that the component recognized by anti-83 was protein in nature.
kDa protein blocked BHV-1 binding to cells
If the 56 kDa protein is important for binding of virus to cells, it would bind the viral attachment protein(s) on the surface of the virus, thus preventing BHV-1 binding to the cells. Biotinylated BHV-1 specifically bound to cells as recognized by a median cell fluorescence (MCF) of 588"2I by 1 2 3 56 kDa flow cytometric analysis (Fig. 7) . When the biotinylated BHV-1 was preincubated with purified 56kDa protein MCF dramatically decreased to 15"82. However, preincubation of BHV-1 with 50 kDa control protein had no significant effect on the virus binding (MCF 509"37).
Discussion
We attempted to use anti-ids as probes to identify the cell surface moiety involved in BHV-1 binding. The anti-ids raised against neutralizing MAb 83 (specific for gB) were used as probes. The available reports emphasize the role of HSV gB in interaction with cell membranes (Kuhn et al., 1990) leading to virus penetration as well as membrane fusion (Cai et al., 1988) . The homologous BHV-1 gB is also required for viral attachment, penetration and BHV-induced cell fusion in bovine cells (Tikkoo et al., 1990; Dubuisson et al., 1992) . Recent studies demonstrated that BHV-1 gB initially binds to heparan sulphate (HS) and then binds with high affinity to a non-HS receptor (Liang et al., 1991; Li et a]., 1995) .
An important criterion for judging the usefulness of the anti-ids as probes in the receptor studies was their ability to protect cells from BHV-I infection, indicating competition for the same cell surface moiety that the virus uses for binding. Initial experiments demonstrated that anti-83 preincubated with MDBK cells reduced BHV-1 infection by up to 65 %. This reduction in BHV-1 plaque formation appeared to be as a result of binding of anti-id to component(s) on the cell surface. In addition, the plaque reduction assay demonstrated that the anti-id can inhibit only BHV-1 infection in MDBK cells and not that of related (PrV) or unrelated virus (BVDV) controls (Fig.  I) . Both the control viruses infect MDBK cells and these results suggested that they use binding sites different from the ones BHV-I uses to infect cells. None of our binding experiments achieved a 100 % inhibition of virus adsorption. This may be accounted for by: (i) there being more than one component on the cells that mediates virus binding; (ii) there may be only a small fraction of internal image anti-ids (Ab2fl) in our preparation, besides the several other populations of Ab2 (~, e);
and (iii) there may be a limited number of cell surface receptors and the anti-id cannot crosslink the surface to prevent virus adsorption to a level of 100 %. Increasing the concentration of anti-id beyond 50 I~g did not result in complete inhibition either. We believe that concentrations above an optimum level result in the relative increase in the population of the Ab2 that structurally interferes with the binding of Ab2r. Anti-ids corresponding to different major glycoproteins used in combination also did not result in the 100% inhibition of infection (results not shown). This could be because of (i) the antibody excess phenomenon or (ii) insufficient concentration of internal image anti-ids in the preparation.
Having shown the ability of the anti-id to compete with BHV-1, we proceeded further to identify the cell surface protein from the MDBK cell membrane preparation. Our study predominantly revealed a 56 kDa cellular protein that was specifically recognized by anti-83 (Fig. 2) . Although the data presented in this study along with another recent report (Thaker et al., 1994) indicate a second receptor other than cell surface heparan sulphate, it is not known whether these two receptor proteins are of a similar nature or are involved in membrane fusion triggered by virus infection. Haywood (1994) reported evidence for sequential interaction of VAPs with the cell surface receptors. Since all herpes viruses express multiple glycoproteins, it is quite possible that they participate in complementary mechanisms for attachment as a possible means of increasing virulence and broadening host range. Further studies might eventually delineate the actual role played by this 56 kDa putative receptor in BHV-I attachment.
To evaluate the internal image of the anti-id an inhibition assay was performed using purified MAbs (Fig. 3a) . In order to obtain a specific anti-idiotype antibody probe it is essential that the attachment site of BHV-1 should be exposed on the virus surface and that this site provide the epitope recognized by neutralizing antibodies. We believe our anti-id satisfies this requirement because the recognition of 56 kDa cellular receptor was inhibited when the anti-id was preincubated with its antigen i.e. MAb 83 but not 24 (MAb against gC of BHV-1) or D89 (MAb against BVDV).
To address the role of 56 kDa protein in binding of BHV-I, an RIP inhibition assay was done using anti-83 as probe. Prior incubation of radiolabelled MDBK membrane proteins with BHV-I, but not BVDV, resulted in abolition of 56 kDa signal in RIPA. This strongly indicated that the anti-id competed for the same binding sites as that of BHV-1. Treatment with PrV did partially interfere with recognition of 56 kDa (Fig. 3 b) . However, our earlier data (Fig. I) demonstrated that anti-83 did not inhibit PrV infection. Since purified membranes were used in RIP inhibition assay some internal binding sites for PrV might have been exposed which were otherwise not available on intact cell monolayers. As a result there was diminished signal in RIPA. PrV attachment is gIII mediated, however, the specific receptor has not yet been identified (Zuckerman et aI., 1989) .
The cell membrane protein to which BHV-1 binds was further characterized by VOPBA. The VOPBA technique has been used to characterize putative cell receptors for a number of virus systems such as reovirus (Choi et aI., I990) , human cytomegalovirus (Adlish eta] ., 1990) and lymphocytic choriomeningitis virus (Borrow & Oldstone, I992) . We used this technique to confirm that our anti-id probe was identifying the same cellular proteins as BHV-I. Our results clearly revealed a protein of similar molecular mass (56 kDa) to the one identified by anti-83 in immunoprecipitation analysis. Membrane proteins preincubated with anti-83 but not anti-D89 prevented BHV-1 from identifying this protein in VOPBA. This confirmed the credibility of our probe in the BHV-1 receptor studies. There was another band of higher molecular mass that was recognized by ~SS-labelled BHV-1 that appears to be of significance because anti-83 pre-treated membranes fail to reveal this band along with 56 kDa. However, our immunoprecipitation analysis using anti-83 never revealed this second band of higher molecular mass. This signal may be due to the interaction of a minor population of other anti-id species in the serum with membrane proteins. As mentioned earlier, virus binding through a specific cell receptor is a biologically relevant event that determines tissue tropism. Whether this band is of any significance in viral attachment needs to be determined. We have examined bat tung cells that are nonpermissive for BHV-1 infection, to determine whether they had 56 kDa protein. Interestingly these cells did not possess the 56 kDa protein by VOPBA using labelled virions ( Fig. 4 ) and as well as RIPA using anti-83 ( Fig. 5 ), suggesting that this putative receptor may be selectively present in permissive cells.
As an attempt to partially characterize the biochemical nature of 56 kDa component, RIPA was done using proteasetreated radiolabelled membranes. The abolition of 56 kDa signal after protease treatment clearly indicated the proteinaceous nature of this putative receptor (Fig. 6 ). Studies are currently in progress to delineate the N-terminal amino acid sequence of this receptor protein.
To understand the specificity of this 56 kDa protein as a receptor for BHV-1, a binding assay was done using biotinylated BHV-1 preincubated with the purified 56 kDa protein.
The 56 kDa cell surface protein bound the VAP(s) on the virus, thus blocking its attachment to the cells, as shown by the reduction in the fluorescence intensity (Fig. 7) . The control 50 kDa protein had a relatively insignificant effect on the binding of biotinylated BHV-1. The biotinylated BHV-1 bound only to purified 56 kDa protein from the plasma membrane, indicating that this protein was recognized by BHV-I VAP(s) in the initial infection process. In summary, our data are consistent with the 56 kDa protein being a specific virus receptor since it is a host cell surface component that participates in virus binding and facilitates viral infection.
